ACE2 and COVID-19: As extensively reviewed by Kruglikov et al.79and Goossens et al.,80 one of the main reasons for poor prognosis of COVID‐19 patients with visceral obesity is an increased number of adipocytes in combination with upregulated ACE2 expression.